You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-Glypican 3 (GPC3) Antibodies

Full name:
anti-Glypican 3 Antibodies (GPC3)
On www.antibodies-online.com are 336 Glypican 3 (GPC3) Antibodies from 22 different suppliers available. Additionally we are shipping Glypican 3 Kits (53) and Glypican 3 Proteins (26) and many more products for this protein. A total of 425 Glypican 3 products are currently listed.
Synonyms:
DGSX, Glypican-3, GPC3, GTR2-2, MXR7, OCI-5, SDYS, SGB, SGBS, SGBS1

Most Popular Reactivities for anti-Glypican 3 (GPC3) Antibodies

Select your species and application

anti-Human Glypican 3 Antibodies:

anti-Mouse (Murine) Glypican 3 Antibodies:

anti-Rat (Rattus) Glypican 3 Antibodies:

All available anti-Glypican 3 Antibodies

Go to our pre-filtered search.

Top referenced anti-Glypican 3 Antibodies

  1. Human Polyclonal Glypican 3 Primary Antibody for EIA, WB - ABIN952555 : Lai, Oseini, Moser, Yu, Elsawa, Hu, Nakamura, Han, Aderca, Isomoto, Garrity-Park, Shire, Li, Sanderson, Adjei, Fernandez-Zapico, Roberts: The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3-dependent Wnt activation. in Hepatology (Baltimore, Md.) 2010 (PubMed)
    Show all 5 references for ABIN952555

  2. Human Polyclonal Glypican 3 Primary Antibody for EIA, IF - ABIN1449428 : Nakatsura, Kageshita, Ito, Wakamatsu, Monji, Ikuta, Senju, Ono, Nishimura: Identification of glypican-3 as a novel tumor marker for melanoma. in Clinical cancer research : an official journal of the American Association for Cancer Research 2004 (PubMed)
    Show all 5 references for ABIN1449428

  3. Human Polyclonal Glypican 3 Primary Antibody for FACS, ICC - ABIN4899915 : Sawada, Yoshikawa, Nobuoka, Shirakawa, Kuronuma, Motomura, Mizuno, Ishii, Nakachi, Konishi, Nakagohri, Takahashi, Gotohda, Takayama, Yamao, Uesaka, Furuse, Kinoshita, Nakatsura: Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunologic evidence and potential for improving overall survival. in Clinical cancer research : an official journal of the American Association for Cancer Research 2012 (PubMed)
    Show all 3 references for ABIN4899915

  4. Human Polyclonal Glypican 3 Primary Antibody for IHC (p), WB - ABIN390317 : Boily, Saikali, Sinnett: Methylation analysis of the glypican 3 gene in embryonal tumours. in British journal of cancer 2004 (PubMed)
    Show all 3 references for ABIN390317

  5. Human Polyclonal Glypican 3 Primary Antibody for IF, WB - ABIN652202 : Wichert, Stege, Midorikawa, Holm, Lage: Glypican-3 is involved in cellular protection against mitoxantrone in gastric carcinoma cells. in Oncogene 2004 (PubMed)
    Show all 3 references for ABIN652202

  6. Cow (Bovine) Polyclonal Glypican 3 Primary Antibody for WB - ABIN2780199 : Bhave, Mars, Donthamsetty, Zhang, Tan, Luo, Bowen, Michalopoulos: Regulation of liver growth by glypican 3, CD81, hedgehog, and Hhex. in The American journal of pathology 2013 (PubMed)
    Show all 2 references for ABIN2780199

  7. Human Monoclonal Glypican 3 Primary Antibody for ICC, FACS - ABIN969523 : Zittermann, Capurro, Shi, Filmus: Soluble glypican 3 inhibits the growth of hepatocellular carcinoma in vitro and in vivo. in International journal of cancer. Journal international du cancer 2010 (PubMed)
    Show all 2 references for ABIN969523

  8. Human Monoclonal Glypican 3 Primary Antibody for EIA, IF - ABIN1107403 : Takai, Ashihara, Ishiguro, Terashima, Watanabe, Kato, Suzuki: Involvement of glypican-3 in the recruitment of M2-polarized tumor-associated macrophages in hepatocellular carcinoma. in Cancer biology & therapy 2010 (PubMed)
    Show all 2 references for ABIN1107403

  9. Human Monoclonal Glypican 3 Primary Antibody for FACS, ICC - ABIN4899916 : Haupt, Murali, Mun, Teplyuk, Mei, Stein, van Wijnen, Nurcombe, Cool: The heparan sulfate proteoglycan (HSPG) glypican-3 mediates commitment of MC3T3-E1 cells toward osteogenesis. in Journal of cellular physiology 2009 (PubMed)

More Antibodies against Glypican 3 Interaction Partners

Human Glypican 3 (GPC3) interaction partners

  1. This is the first study in which the optimal HLA-A*0201 GPC3 epitopes were screened from a large number of candidates predicted by three software. The optimized HLA-A*0201 GPC3 peptides will provide new epitope candidates for hepatocellular carcinoma (HCC (show FAM126A Antibodies)) immunotherapy.

  2. GPC3 and KRT19 (show KRT19 Antibodies) overexpression are associated with carcinogenesis, progression, and poor prognosis in patients with PDAC and a valuable biomarker for diagnosis of PDAC.

  3. The clinical implication of GPC3 detection and targeting in the management of patients with hepatocellular carcinoma. Review.

  4. Glypican 3 expression showed a significant difference between endometrioid endometrial carcinoma and serous endometrial carcinoma, and it was significantly correlated with tumor grade, stage and myometrial invasion

  5. Data show that notum (show NOTUM Antibodies) and glypican-1 (show GPC1 Antibodies) and glypican-3 gene expression during colorectal cancer (CRC (show CALR Antibodies)) development and present evidence to suggest them as potential new biomarkers of CRC (show CALR Antibodies) pathogenesis.

  6. GPC3 expression was measured in hepatocellular carcinoma at different stages and correlated with prognosis. CK19 (show KRT19 Antibodies)+/GPC3+ HCC (show FAM126A Antibodies) has the highest risk of intrahepatic metastasis, microvascular invasion, regional lymph node involvement, and distant metastasis.

  7. Review: Glypican-3 is a highly specific biomarker for the diagnosis of hepatocellular carcinoma and a promising therapeutic target.

  8. In South Korean hepatocellular carcinoma patients, GPC3 expression was more frequent in hepatocellular carcinoma with aggressive features, but it was not an independent prognostic biomarker.

  9. In this meta-analysis, GPC3 was found to be acceptable as a serum marker for the diagnosis of hepatocellular carcinoma.

  10. GPC3 may be a candidate marker for detecting lung squamous cell carcinoma.

Mouse (Murine) Glypican 3 (GPC3) interaction partners

  1. Data show that notum (show NOTUM Antibodies) and glypican-1 (show GPC1 Antibodies) and glypican-3 gene expression during colorectal cancer (CRC (show SCRIB Antibodies)) development and present evidence to suggest them as potential new biomarkers of CRC (show SCRIB Antibodies) pathogenesis.

  2. Coupling of pGPC3 to liposomes was essential for effective priming of GPC3-specific CTLs.

  3. The expression of GPC-3 was altered by DEN treatment.

  4. Data suggest that GPC3 down-regulates hepatocyte proliferation by binding to hedgehog (show SHH Antibodies) (HH) and down-regulating the HH signaling pathway and binding with CD81 (show CD81 Antibodies), thus making it unavailable to bind to Hhex (show HHEX Antibodies) and causing its nuclear translocation.

  5. Finding represents a rare four layer genomic overlap consisting of growth associated quantitative trait locus (QTL), body mass associated Gpc3 gene, highly conserved miRNA gene and mature miRNA seed SNP identified in the lean mouse.

  6. Hepatocyte overexpression of GPC3 suppresses hepatocyte proliferation and liver regeneration and alters gene expression profiles.

  7. glypican-3 is involved in the recruitment of M2-polarized tumor-associated macrophages in hepatocellular carcinoma

  8. GPC3 inhibits the PI3K/Akt (show AKT1 Antibodies) anti-apoptotic pathway while it stimulates the p38MAPK (show MAPK14 Antibodies) stress-activated one in murine mammary adenocarcinoma LM3 cells

  9. Gpc3 function in development of Simpson-Golabi-Behmel syndrome is IGF-independent

  10. GPC3 knockout mice exhibit alterations in the Wnt (show WNT2 Antibodies) signaling pathway, which is also associated with the regulation of cell proliferation

Glypican 3 (GPC3) Antigen Profile

Antigen Summary

Cell surface heparan sulfate proteoglycans are composed of a membrane-associated protein core substituted with a variable number of heparan sulfate chains. Members of the glypican-related integral membrane proteoglycan family (GRIPS) contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol linkage. These proteins may play a role in the control of cell division and growth regulation. The protein encoded by this gene can bind to and inhibit the dipeptidyl peptidase activity of CD26, and it can induce apoptosis in certain cell types. Deletion mutations in this gene are associated with Simpson-Golabi-Behmel syndrome, also known as Simpson dysmorphia syndrome. Alternative splicing results in multiple transcript variants.

Alternative names and synonyms associated with Glypican 3 (GPC3)

  • glypican 3 (gpc3) antibody
  • glypican 3 (GPC3) antibody
  • glypican 3 (Gpc3) antibody
  • DGSX antibody
  • Glypican-3 antibody
  • GPC3 antibody
  • GTR2-2 antibody
  • MXR7 antibody
  • OCI-5 antibody
  • SDYS antibody
  • SGB antibody
  • SGBS antibody
  • SGBS1 antibody

Protein level used designations for anti-Glypican 3 (GPC3) Antibodies

glypican 3 , glypican-3-like , glypican proteoglycan 3 , glypican-3 , heparan sulphate proteoglycan , intestinal protein OCI-5 , secreted glypican-3 , defective in Simpson-Golabi-Behmel overgrowth syndrome , proteoglycan GPC3 , Intestinal protein OCI-5

GENE ID SPECIES
387365 Danio rerio
706773 Macaca mulatta
100023253 Monodelphis domestica
100135027 Xenopus (Silurana) tropicalis
100401118 Callithrix jacchus
100444952 Pongo abelii
100477314 Ailuropoda melanoleuca
100548246 Meleagris gallopavo
100591673 Nomascus leucogenys
2719 Homo sapiens
481056 Canis lupus familiaris
615239 Bos taurus
14734 Mus musculus
25236 Rattus norvegicus
100351858 Oryctolagus cuniculus
100726246 Cavia porcellus
100516171 Sus scrofa
770863 Gallus gallus
101119285 Ovis aries
465866 Pan troglodytes
Selected quality suppliers for anti-Glypican 3 (GPC3) Antibodies
Did you look for something else?